Literature DB >> 5476865

Megaloblastic anaemia of pregnancy: a clinical and laboratory study with particular reference to the total and labile serum folate levels.

P G Rae, P M Robb.   

Abstract

It has been shown that the incidence of megaloblastic anaemia in a group of 463 randomly selected pregnant women receiving iron was 12 times as high as in a control group of 235 pregnant women receiving iron and folic acid. The incidence of all types of anaemia in the women receiving iron alone was more than three times the incidence in those having iron and folic acid. Some women who were not anaemic or who had normoblastic anaemia had serum folate levels in the same range as the women with megaloblastic anaemia, but none of the women with megaloblastic anaemia had high serum folate levels. The labile fraction of the serum folate was no more reliable than the total serum folate as a diagnostic criterion of megaloblastic erythropoiesis in the individual case. The blood group distribution in the women with megaloblastic anaemia was the same as in the general population. Babies born to mothers with megaloblastic anaemia tended to be smaller than the rest, although there was no difference in the placental weights. The significance of these findings is discussed.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5476865      PMCID: PMC476777          DOI: 10.1136/jcp.23.5.379

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  10 in total

1.  AETIOLOGICAL FACTORS IN ABRUPTIO PLACENTAE.

Authors:  B M HIBBARD; E D HIBBARD
Journal:  Br Med J       Date:  1963-12-07

2.  SERUM-FOLIC-ACID IN RECURRENT ABORTIONS.

Authors:  R H MARTIN; T A HARPER; W KELSO
Journal:  Lancet       Date:  1965-03-27       Impact factor: 79.321

3.  Clinical analysis of 100 cases of severe megaloblastic anaemia of pregnancy.

Authors:  P B GATENBY; E W LILLIE
Journal:  Br Med J       Date:  1960-10-15

4.  Blood-group distribution in megaloblastic anaemia of pregnancy.

Authors:  C GILES
Journal:  Lancet       Date:  1960-11-12       Impact factor: 79.321

5.  Megaloblastic erythropoiesis in pregnancy.

Authors:  A MACKENZIE; J ABBOTT
Journal:  Br Med J       Date:  1960-10-15

6.  Serum folic acid levels in pregnancy and their relationship to megaloblastic marrow change.

Authors:  I J Temperley; M J Meehan; P B Gatenby
Journal:  Br J Haematol       Date:  1968-01       Impact factor: 6.998

7.  Effect of serum-factors other than folate on the Lactobacillus casei assay.

Authors:  J D Cowan; A V Haffbrand; D L Mollin
Journal:  Lancet       Date:  1966-01-01       Impact factor: 79.321

8.  An account of 335 cases of megaloblastic anaemia of pregnancy and the puerperium.

Authors:  C Giles
Journal:  J Clin Pathol       Date:  1966-01       Impact factor: 3.411

9.  MICROBIOLOGICAL ASSAY OF FOLIC ACID ACTIVITY IN HUMAN SERUM.

Authors:  G H SPRAY
Journal:  J Clin Pathol       Date:  1964-11       Impact factor: 3.411

10.  FOLIC ACID AND VITAMIN B12 LEVELS IN PREGNANCY AND THEIR RELATION TO MEGALOBLASTIC ANAEMIA.

Authors:  E W BALL; C GILES
Journal:  J Clin Pathol       Date:  1964-03       Impact factor: 3.411

  10 in total
  4 in total

1.  Folate supplements during pregnancy.

Authors:  K H Trigg; E J Rendall; A Johnson; F R Fellingham; T A Prankerd
Journal:  J R Coll Gen Pract       Date:  1976-03

Review 2.  Daily oral iron supplementation during pregnancy.

Authors:  Juan Pablo Peña-Rosas; Luz Maria De-Regil; Maria N Garcia-Casal; Therese Dowswell
Journal:  Cochrane Database Syst Rev       Date:  2015-07-22

Review 3.  Daily oral iron supplementation during pregnancy.

Authors:  Juan Pablo Peña-Rosas; Luz Maria De-Regil; Therese Dowswell; Fernando E Viteri
Journal:  Cochrane Database Syst Rev       Date:  2012-12-12

Review 4.  Errors in the implementation, analysis, and reporting of randomization within obesity and nutrition research: a guide to their avoidance.

Authors:  Colby J Vorland; Andrew W Brown; John A Dawson; Stephanie L Dickinson; Lilian Golzarri-Arroyo; Bridget A Hannon; Moonseong Heo; Steven B Heymsfield; Wasantha P Jayawardene; Chanaka N Kahathuduwa; Scott W Keith; J Michael Oakes; Carmen D Tekwe; Lehana Thabane; David B Allison
Journal:  Int J Obes (Lond)       Date:  2021-07-29       Impact factor: 5.095

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.